Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Apolipoprotein B levels

APOB · rs12713559

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−27, with 8 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 340,860 European ancestry individuals, 5,962 African ancestry individuals, 7,275 South Asian ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.401 higher (95% confidence interval 0.33-0.47); p = 7 × 10−28.

Where it sits Chromosome 2, band 2p24.1 — a missense change in APOB.

What ClinVar records

Classification Conflicting classifications of pathogenicity for Hypercholesterolemia, familial, 1, Hypercholesterolemia, autosomal dominant, type B, Cardiovascular phenotype, Familial hypobetalipoproteinemia 1, APOB-related disorder and 1 more; criteria provided, conflicting classifications (1 of 4 stars, 21 submitters), last evaluated 2026-08-21. ClinVar record 17897 NM_000384.3(APOB):c.10672C>T (p.Arg3558Cys)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-16 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AG
Korean Korea4K
A 0.0% · G 100.0%
Japanese ToMMo
A 0.0% · G 100.0%
World gnomAD
A 0.1% · G 100.0%
World 1000 Genomes
A 0.0% · G 100.0%
World TOPMed
A 0.1% · G 99.9%

By ancestry gnomAD

European (non-Finnish)
G 100.0%
African / African American
G 99.9%
Admixed American (Latino)
G 100.0%
Ashkenazi Jewish
G 99.9%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Apolipoprotein B levels. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Apolipoprotein B levels. That is a smaller link than two copies.
G/G No copy of the version the research linked to Apolipoprotein B levels. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Apolipoprotein B levels (rs12713559). MyGeneLog™. https://www.mygenelog.com/variants/rs12713559

← See all variants